Desogestrel: Clinical Trials

16 trials of Desogestrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 2 recruiting, 2 terminated. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 5, Unknown 4, Recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1

Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life
Phase 4RecruitingUniversity Hospital, Ghent602025-01-272025-12-26
Oral Contraceptive Pill (OCP) Pharmacogenomics
Desogestrel / Ethinyl Estradiol Pill - Contraception, Pharmacogenomic Drug Interaction
Phase 4RecruitingYale University7002024-10-292026-07-16
Desogestrel-containing COCP Pharmacokinetic Validation Study
Desogestrel and Ethinyl Estradiol Tablets - Contraception
Phase 4CompletedUniversity of Colorado, Denver222021-09-102025-05-30
Desogestrel Versus GnRH Antagonist in IVF/ICSI
Desogestrel 0.075 MG, Orgalutran - IVF, Infertility
Phase 4UnknownCasa di Cura Privata Villa Mafalda1652020-10-012021-01-28
Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy(LLLT) for Primary Dysmenorrhea(PD)
low level light therapy, DING KUN DAN, Simulated drug of DING KUN DAN - Primary Dysmenorrhea, Traditional Chinese Medicine
Phase 4UnknownPeking Union Medical College Hospital4802019-06-222019-06-25
Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors
FSH-CTP + DESOGESTREL - Infertility
Phase 4WithdrawnFundacion Dexeus2016-05-012018-09-05
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
Combined Oral Contraceptive, Transdermal Contraceptive, Contraceptive Vaginal Ring - Bone; Disorder, Development and Growth
Phase 4CompletedPenn State University602015-01-012020-03-09
Assessing the Impact of Contraceptives on Bone Health Using 41Ca
Combined Oral Contraceptive (COC), Contraceptive Vaginal Ring (CVR) - Other Disorders of Bone Development and Growth
Phase 4Active not recruitingPenn State University62015-01-012026-07-06
NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Contraceptives, Oral, Contraceptive, Vaginal ring - Infertility
Phase 4TerminatedClinique Ovo72012-07-012015-07-27
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
Dienogest, Goserelin, Desogestrel - Uterine Leiomyoma
Phase 4TerminatedUniversity of Sao Paulo142012-01-012020-08-13
Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?
Desogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon), Etonogestrel 68 mg subdermal implant - Bleeding
Phase 4UnknownVL-Medi Oy902011-09-012011-09-22
New Treatments for Troublesome Bleeding in Implanon Users
Marvelon - Menstrual Problem
Phase 4UnknownFamily Planning Association New South Wales2002011-07-012011-06-29
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
EE 20 microgram with desogestrel 150 mg, EE 20 microgram with drospirenone 3 mg - Premenstrual Syndrome
Phase 4CompletedChulalongkorn University902011-06-012012-03-14
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Oral contraceptive pill and microdose lupron, E2 patch/antagonist - Infertility
Phase 4WithdrawnWeill Medical College of Cornell University2009-01-012013-06-25
An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment
Ethinyl estradiol/Norgestimate (EE/NGM), Ethinyl estradiol/Desogestrel (EE/DSG) - Acne Vulgaris
Phase 4CompletedJanssen-Cilag Ltd.,Thailand2012008-12-012013-06-19
Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)
Marvelon - Infertility
Phase 4CompletedOrganon and Co4422006-10-012022-02-04

Conditions studied

Infertility (5)  ·  Acne Vulgaris (1)  ·  Hemorrhage (1)  ·  Menstruation Disturbances (1)  ·  Myofibroma (1)  ·  Premenstrual Syndrome (1)

Sponsors

Penn State University (2)  ·  Casa di Cura Privata Villa Mafalda (1)  ·  Chulalongkorn University (1)  ·  Clinique Ovo (1)  ·  Family Planning Association New South Wales (1)  ·  Fundacion Dexeus (1)  ·  Janssen-Cilag Ltd.,Thailand (1)  ·  Organon and Co (1)  ·  Peking Union Medical College Hospital (1)  ·  University Hospital, Ghent (1)  ·  University of Colorado, Denver (1)  ·  University of Sao Paulo (1)  ·  VL-Medi Oy (1)  ·  Weill Medical College of Cornell University (1)  ·  Yale University (1)

Countries

United States (5)  ·  Thailand (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Finland (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Mary Jane De Souza, PhD (2)  ·  Aaron M Lazorwitz, MD, PhD (1)  ·  Dan Apter, Docent (1)  ·  Edith Weisberg, MB BS MM (1)  ·  Jacques Kadoch, MD (1)  ·  Jirath Wichianpitaya, M.D. (1)  ·  Luiz Gustavo O Brito, MD, PhD (1)  ·  Surasak Taneepanichskul, M.D. (1)  ·  Zev Rosenwaks, M.D. (1)

Results publications

PMID 21954280, PMID 24903202, PMID 25074072, PMID 32612574, PMID 35028764, PMID 37331464, PMID 39615778

NIH funding

2023 (1), R01HD111436 (1)